Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Naplex
Anticoagulation - clinical pearl
| Question | Answer |
|---|---|
| What anticoagulant is safe for pregnancy | Enoxaparin (Lovenox) |
| TRUE or FALSE: warfarin is safe for pregnancy | FALSE |
| List of teratogenic medications | Warfarin ACE inhibitors Isotretinoin Lithium Methotrexate NSAIDs Phenytoin Topiramate Valproate |
| What anticoagulant inhibits on both Xa, IIa | Heparin (ratio 1:1), Enoxaparin (Lovenox, ratio 2:1 ) |
| What factor does warfarin inhibit? | factor VII, IX, X and II |
| What are Direct Factor Xa Inhibitors (PO)? | Rivaro - Xa - ban Api - Xa - ban Edo - Xa - ban |
| TRUE or FALSE: adjust heparin dose if CrCl < 30 mL/min | FALSE, No dose adjustment for heparin in pt w renal dysfunction |
| Heparins VTE Ppx Dosing | 5,000 units SC Q8-12H |
| Enoxaparin (Lovenox) VTE Ppx Dosing | 30 mg SC Q12H or 40 mg SC QD If CrCl < 30 mL/min: 30 mg SC QD |
| Heparins VTE treatment dose | Bolus 80 units/kg IV, then infuse 18 units/kg/hr IV |
| Heparins ACS (STEMI, NSTEMI, UA) treatment dose | Bolus 60 units/kg IV, then infuse 12 units/kg/hr IV |
| Heparin treatment dosing for VTE vs ACS memorize | VTE: 80 -18 ACS: 60 -12 Bolus for both heart and non-heart |
| What body weight used to calculate dosing of heparin and Enoxaparin | For Ppx, dosing regardless to body weight For treatment, use total body weight |
| Enoxaparin (Lovenox) treatment dosing for VTE and and UA/NSTEMI | 1 mg/kg SC Q12H If CrCl < 30 mL/min: dosing every 24H |
| Enoxaparin (Lovenox) treatment dosing for STEMI | for pt < 75 yrs Bolus 30 mg IV, then immediately start 1 mg/kg SC Q12H If CrCl < 30 mL/min: dosing every 24H |
| Heparin-induced thrombocytopenia | Platelets reduction > 50% within 5-10 days after starting heparin D/C & start an IV DTI (eg, Argatroban or Bivalirudin) |
| What are Direct Thrombin Inhibitors (DTIs) | DTIs inhibit IIa: Dabigatran (PO), Argatroban (IV), Bivalirudin (IV) IV DTIs: used in cath lab / HIT |
| BOXED WARNING for enoxaparin | Hematomas/paralysis in patients receiving neuraxial anesthesia (punch the spine) |
| Therapeutic monitoring for heparin | aPTT, 6 hours after infusion starts or rate changes |
| heparin Antidote | Protamine |
| Therapeutic monitoring for Enoxaparin (Lovenox) | NOT require, OR Anti-Xa PRN four hour post dose peak level, for: pregnant, renal dysfunction, elderly, or extreme body weight (obese or very low body weight) |
| Enoxaparin Counseling points | • the air bubble in the syringe should not be expelled • Skin pinched to create a fold • Needle inserted / removed at 90-degree angle • patients should avoid rubbing the site of injection • rotate the injection sites to minimize bruising |
| Apixaban (Eliquis) dosing for Afib | 5 mg PO BID, OR half dose if 2.5 mg PO BID if 2 of the following: age ≥80 years, weight ≤ 60 kg, SCr ≥ 1.5 mg/dL |
| Apixaban (Eliquis) dosing for VTE | Loading dose: 10 mg PO BID x 7 days Maintenance dose: 5 mg PO BID |
| Rivaroxaban (Xarelto) dosing for Afib | 20 mg PO daily If CrCl ≤ 50 mL/min: 15 mg PO daily |
| Rivaroxaban (Xarelto) dosing for VTE | Loading dose: 15 mg PO BID x 21 days Maintenance dose: 20 mg PO daily |
| What Rivaroxaban (Xarelto) requires taking with foods? | Doses ≥ 15 mg should be taken with dinner |
| What DOACs require taking with food | Rivaroxaban (Xarelto) with doses ≥ 15 mg |
| Andexxa (andexanet alfa) | Antidote for both: Apixaban (Eliquis) & Rivaroxaban (Xarelto) |
| Dabigatran (Pradaxa) dosing for both AF and VTE | For VTE: MUST use 5-10 days of parenteral anticoagulant first (bridging) Then: 150 mg PO BID |
| What DOACs require keeping in original container | Dabigatran (Pradaxa), discard 4 months after opening (capsule) or 6 months (pelletes) |
| Praxbind (idarucizumab) is | Antidote for Pradaxa |
| what CrCl value that do not use Edoxaban as its efficacy reduced? | • AF only: do not use if CrCI > 95 mL/min |
| What DOACs need parenteral anticoagulant bridging for VTE | Dabigatran (Pradaxa) & Edoxaban: 5-10 days warfafin: min 5 days and until the INR is ≥ 2 for at least 24 hours. |
| Oral anticoagulant dosing for VTE treatment - bridging days | 5 - 7 (apixatran) - 21 (rivaroxaban) |
| Edoxaban dosing for Afib | • 60 mg PO daily • CrCI < 15 or > 95 mL/min: avoid use • CrCI 15-50 mL/min: 30 mg PO daily |
| what anticoagulants used in patients with prosthetic heart valves | warfarin |
| what anticoagulants have box warning of neuraxial anesthesia | DOACs, heparin / lovenox |
| Warfarin dosing | Healthy out pt: 10 mg for the first 2 doses, then adjust to INR goal. Use a starting dose of ≤ 5 mg for • HF • Liver disease • Malnutrition • Elderly • High risk of bleeding (including from drugs that increase warfarin levels) |
| Warfarin tablet colors | Please - Let - Greg - Brown - Bring - Peaches - To - Your - Wedding Pink (1mg) - Lavender (2mg) - Green (2.5 mg) - Brown/Tan (3 mg) - Blue (4 mg) - Peach (5 mg) - Teal (6 mg) - Yellow (7.5 mg) - White (10 mg) 1 - 2 - 2.5 - 3 - 4 - 5 - 6 - 7.5 - 10 |
| Warfarin Antidotes | vitamin K (phytonadione), prothrombin complex concentrate (PCC) |
| warfarin INR goals | • 2-3 for most indications • 2.5-3.5 for mechanical mitral valve OR mechanical aortic valve + another indication for anticoagulation |
| Managing warfarin bleeding risk based on INR | • INR < 4.5 w/o bleeding: Reduce or skip warfarin dose • INR 4.5-10 w/o bleeding: Hold 1-2 doses of warfarin • INR > 10 w/o bleeding: Hold warfarin, vit K 2.5-5 mg PO • Major bleed: Hold warfarin, vit K 5-10 mg (slow IV) AND 4-factor PCC |
| CYP2C9 DDI which increase INR Warfarin "MAT" Drugs | M - metronidazole and macrolides (Clarithromycin, Erithromyein) A - amiodarone and azole antifungals T - trimethoprim/sulfamethoxazole |
| Warfarin concurrent use w Amiodarone | dose reduction 30-50% |
| Major CYP2C9 inducers reduce INR | Remember: Review Patient Profiles and Counsel Soon • Rifampin • Phenytoin • Phenobarbital • Carbamazepine • St. John's wort |
| Warfarin Additive bleeding risk w/o increase in INR | • NSAIDs, aspirin (and other antiplatelet drugs), SSRIs and SNRIs • Natural products: "the 5 G's": Garlic, ginger, ginkgo biloba, ginseng, glucosamine |
| Only indication which warfarin is indicated for pregnant women | warfarin is teratogenic, considered to be contraindicated in pregnant patients. The exception is pregnant patients with a mechanical heart valve |
| What anticogulants are prefered for DVT of leg or PE WITHOUT cancer | Dabigatran, rivaroxaban, apixaban, or edoxaban are recommended over warfarin for the duration of treatment |
| What anticogulants are prefered for DVT of leg or PE WITH cancer | • Rivaroxaban, apixaban, or edoxaban are recommended over LMWH for initiation AND treatment phases of therapy • Dabigatran is NOT preferred |
| how long anticoagulants are indicated for DVT | 3 months- provoked DVT ( prolonged treatment need or unprovoked DVT.) |
| CHA2DS2-VASc Scores (2 for: age ≥ 75 years and stroke) | 1 C - congestive heart failure 1 H - hypertension 2 A - age ≥ 75 years 1 D - diabetes 2 S - stroke 1 V - vascular disease 1 A - age 65-74 years 1 Sc - sex category (1 for female) |
| CHA2DS2-VASc Scores for indication of anticoagulants | • consider if score is 1 for male and 2 for female • indicate anticoagulant if score is 2 for male and 3 for female |
| From warfarin to another oral DOACs, stop warfarin and convert to (READ 3-2.5-2) | • Rivaroxaban when INR is < 3 • Edoxaban when INR is ≤ 2.5 • Apixaban when INR is < 2 • Dabigatran when INR is < 2 |
| Modifiable risk factors for VTE | • Acute medical illness • Immobility • Medications: ESAs (Epoetin, Darbepoetin), Estrogen-containing, SERMs (Tamoxifen and Raloxifene) • BMI ≥ 30 • Pregnancy & postpartum • Recent surgery or trauma |
| Nonmodifiable risk factors for VTE | • Increasing age • Cancer • Heart failure • Known thrombophilia • Antiphospholipid syndrome • Antithrombin deficiency • Factor V Leiden mutation • Protein C or S deficiency • Previous VTE • Respiratory failure |
| Symptoms of Life-threatening bleeding due to anticoagulants | Hypotension, tachycardia, bleeding, low hemoglobin/hematocrit |
| what dose of vit K and route if INR > 10 w None or minimal bleeding | • Hold warfarin • Administer 2.5-5 mg oral vitamin K • Resume warfarin at a lower dose when INR is therapeutic |
| what dose of vit K and route if pt experiences Serious or life threatening | • Hold warfarin • Administer IV vitamin K 5-10 mg & 4-PCC* |
| DDI between levofloxacin and warfarin | increase bleeding risk / INR (Alteration of intestinal flora: quinolones, tetracyclines) |
| TRUE or FALSE: pt on anticoagulant can take advil or Doan's for pain control | FALSE, Tylenol is the safe option |
| Vit K (phytonadione) 10 mg inject intravenously, what is the SE? | Hypersensitivity reaction |
| Can vit K be administrated via SC? | NO, Unpredictable absorption |
| what is the Parenteral route for phytonadione for bleeding due to warfarin | • Avoid IM route due to the risk of hematoma • SC Unpredictable absorption • IV. To mimimize the risk of a hypersensitivity reaction, the drug must be diluted in a minimum of 50 mL and administered at a slow rate, not to exceed 1 milligram per minute. |
| Patients with factor VIII deficiency are at risk of clotting or bleeding? | Bleeding risk Factor VIII deficiency is a form of hemophilia (cannot properly form a blood clot and are at high risk of bleeding) |
| Patients with factor III and V deficiency are at risk of clotting or bleeding? | Clotting risk |
| What anticoagulants are prefer in pt w cancer | Oral factor Xa inhibitors and LMWHs (after Xa inhibitors or pts w certain GI malignancies) |
| INR goal for pt w mitral Mechanical valves | 2.5 - 3.5 |
| INR goal of 2.5-3.5 if | • Mechanical aortic valve with at least 1 risk factor • Mechanical mitral valve • Two mechanical heart valves |
| INR and albumin relation | Because warfarin is highly protein-bound, free drug levels increase in the presence of hypoalbuminemia, thereby increasing INR and bleeding risk |
| Low albumin | High INR and bleeding risk (high free drug level) |
| pt on anticoagulants w findings that indicate bleeding include | • ecchymosis - Xuất huyết dưới da • epistaxis - Chảy máu cam • hemoptysis - Ho ra máu • menorrhagia - Rong kinh |
| Pharmacogenomic testing for warfarin incl | CYP2C9*2 & *3, VKORC1 (CYP2C9*2/*3 alleles are associated with an increased risk of bleeding and need for a lower maintenance dose) |
| Protamine dose as an reversal for heparin IV | 1 : 100 (dose calculated for the last 2 hrs) No more than 50 mg of protamine should be given in one dose. |
| after Cardioversion, when will be the soonest to d/c anticoagulants | minimum 4 weeks (prior cardioversion, pt is on 3 wks of anticoagulants) |
| Foods cause reduction of INR | • Brussel sprouts • Kale • Spinach |
| Rivaroxaban (Xarelto) 15 mg PO BID - missing dose | • Take a missed dose as soon as possible • Two tablets may be taken at once if it is close to the next dose |
Created by:
dao.vo11017